Roll out of Cambridge-developed artificial pancreas is world first
An artificial pancreas developed with the help of staff and patients at Addenbrooke's Hospital is one of four new devices to be rolled out by the NHS - helping tens of thousands of children and adults living with type one diabetes.
The ground-breaking device - pioneered by Cambridge-based Professor Roman Hovorka and called the CamAPS FX app - continually monitors a person's blood glucose, then automatically adjusts the amount of insulin given to them through a pump.
It is the only device that has been fully developed in the UK and the only one suitable for women who are pregnant.
Professor Hovorka said:
"It is very exciting that a device developed in Cambridge with the help of local experts and local people will now become accessible to patients all over the country"
"It will enable them to spend less time having to focus on managing their condition and worrying about the blood sugar levels, and more time getting on with their lives"
For more information visit: CUH News
Published April 5 2024
Latest from CCTU
Research sets global standard for Crohn’s treatment
Trial results published by Cambridge researchers earlier this year and involving patients at Addenbrooke’s Hospital are helping to set new global standards…
Team praised for “game-changing” heart trial
A senior Addenbrooke’s early phase trials researcher has praised patients, staff and sponsors who backed a landmark trial which could be a “game changer” in…
Improving outcomes for Crohn's patients
Treating newly-diagnosed patients with advanced therapy leads to dramatic improvements in outcomes.
